ANN ARBOR STAGE IVA HODGKIN LYMPHOMA
Clinical trials for ANN ARBOR STAGE IVA HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE IVA HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE IVA HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for older hodgkin patients: Chemo-Free combo shows promise
Disease control OngoingThis study tests a combination of two drugs, nivolumab and brentuximab vedotin, in people aged 60 and older (or younger people who cannot tolerate standard chemotherapy) with untreated Hodgkin lymphoma. The goal is to see if this drug pair can shrink or eliminate the cancer witho…
Matched conditions: ANN ARBOR STAGE IVA HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
New combo therapy shows promise against tough childhood cancer
Disease control OngoingThis study tests whether adding the targeted drug brentuximab vedotin to standard chemotherapy works better than chemo alone for children and young adults with high-risk Hodgkin lymphoma. About 600 participants with advanced stages of the disease will be randomly assigned to one …
Matched conditions: ANN ARBOR STAGE IVA HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC